How to manage urinary retention after ureteral stent placement?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Urinary Retention After Ureteral Stent Placement

Immediate catheter drainage is the primary treatment for urinary retention following ureteral stent placement, with urgent evaluation to identify and address the underlying cause.

Immediate Management

  • Place or maintain a urethral catheter to decompress the bladder and relieve retention 1, 2
  • Measure post-void residual volume if the patient can void at all to quantify the degree of retention 2
  • Assess for signs of infection (fever, leukocytosis, cloudy urine) as infected obstructed systems require urgent intervention 2, 3
  • If sepsis or fever is present with retention, obtain urine cultures before and after decompression and initiate immediate antibiotics 2

Diagnostic Evaluation

Identify the specific cause of retention through targeted assessment:

  • Evaluate stent position and patency using plain radiography (KUB) or ultrasound to rule out stent migration (occurs in ~5% of cases) or malposition 1, 3
  • Assess for bladder outlet obstruction through physical examination looking for prostatic enlargement, urethral stricture, or blood clots 3
  • Rule out stent-related complications including encrustation (more common with prolonged indwelling time >3 months), infection, or bladder spasm causing functional obstruction 4, 5, 6
  • Consider CT imaging if there are signs of significant complications such as perinephric stranding, obstruction despite stent presence, or concern for ureteral injury 2, 3

Specific Management Based on Etiology

If Stent Migration or Malposition is Identified:

  • Cystoscopic repositioning or replacement is required for confirmed stent migration 3
  • This should be performed urgently if associated with obstruction or infection 3

If Bladder Spasm or Irritative Symptoms are Predominant:

  • NSAIDs (diclofenac, ibuprofen) are first-line for stent-related pain and spasm, as they decrease ureteral smooth muscle tone 2, 7
  • Use the lowest effective dose to minimize cardiovascular and gastrointestinal risks 7
  • Alpha-blockers can be considered for patients with contraindications to NSAIDs or as adjunctive therapy 7
  • Anticholinergics may help reduce bladder spasm if irritative symptoms are severe 7

If Stent Encrustation is Present:

  • Multimodality endoscopic approach is required for severely encrusted stents, potentially including cystolitholapaxy, ureteroscopy, and lithotripsy 6
  • Do not attempt forced removal of heavily encrusted stents as this can cause ureteral avulsion or retained fragments 4, 6
  • Average of 2-3 procedures may be needed for complete removal of severely encrusted retained stents 6

If Infection is Present:

  • Third-generation cephalosporin (ceftazidime) is superior to fluoroquinolones for infected obstructed systems 2
  • Adjust antibiotics based on culture results 2
  • Intensive care may be necessary in severe sepsis cases 2

When to Remove or Replace the Stent

  • Early stent removal should be considered if severe, refractory symptoms persist despite medical therapy and the original indication for stenting has resolved 7, 3
  • Persistent severe pain unresponsive to management after 48-72 hours warrants urologic consultation for potential stent removal 3
  • Signs requiring immediate urologic intervention include anuria, severe flank pain, rising creatinine, or signs of obstruction despite stent presence 3

Critical Pitfalls to Avoid

  • Do not delay urologic consultation if there are signs of stent migration, obstruction, or severe uncontrolled pain 3
  • Do not ignore signs of infection (fever, leukocytosis) as progression to urosepsis can be rapid 3
  • Do not attempt blind catheterization if urethral injury is suspected, as this can worsen the injury 3
  • Do not force removal of encrusted stents, as this can cause ureteral avulsion or leave retained fragments 4, 6

Follow-up Considerations

  • Catheter drainage for uncomplicated extraperitoneal bladder issues typically requires 2-3 weeks with follow-up imaging to confirm healing 1
  • Regular assessment of symptom control and medication side effects is essential 7
  • If retention persists beyond initial catheter drainage, cystoscopy may be needed to evaluate for anatomic obstruction or stent-related complications 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Ureteral Obstruction

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Pain After Fall with Urethral Stent in Place

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Ureteral Stent-Associated Spasm

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.